Prometrium Manufacturer Copay Program: How to Cut Your Cost in 2026

Prescription access and medication affordability image for Prometrium Manufacturer Copay Program: How to Cut Your Cost in 2026

At a glance

  • Drug / Prometrium (micronized progesterone), oral capsules 100 mg and 200 mg
  • Manufacturer / AbbVie (acquired from Solvay Pharmaceuticals)
  • Average retail cash price / approximately $45 per 30-day supply (2026)
  • Compounded alternative average / approximately $25 per 30-day supply
  • Generic availability / Yes. Generic micronized progesterone capsules are widely available.
  • Copay card eligibility / Commercially insured patients only; Medicare and Medicaid patients are typically excluded
  • Patient assistance program / AbbVie myAbbVie Assist may cover uninsured or underinsured patients
  • Key caveat / Copay program terms change frequently. Verify directly at abbvie.com or with your pharmacist before relying on any coupon value.

What Is Prometrium and Why Does Cost Matter?

Prometrium is the brand-name oral capsule formulation of micronized progesterone, a bioidentical hormone used in menopausal hormone therapy (MHT) and to support luteal-phase function in certain fertility protocols. The FDA approved Prometrium in 1998 for prevention of endometrial hyperplasia in postmenopausal women receiving conjugated estrogens and for secondary amenorrhea.

Cost is a real barrier. A 2023 JAMA Internal Medicine analysis found that out-of-pocket spending on hormone therapy varies widely depending on insurance tier placement, with progesterone products frequently landing on non-preferred tiers that require higher patient cost-sharing (JAMA Internal Medicine, 2023). For women who are uninsured or whose plan does not cover HRT, a 30-day supply of brand Prometrium can cost substantially more than the average $45 cash price at discount pharmacies if purchased at full retail.

How Micronized Progesterone Differs from Synthetic Progestins

Prometrium contains micronized progesterone, which is chemically identical to the progesterone produced by the human ovary. Synthetic progestins such as medroxyprogesterone acetate (MPA) bind progesterone receptors with different affinity profiles and carry different cardiovascular and breast-tissue signals.

The Women's Health Initiative (WHI) Memory Study and subsequent re-analyses have suggested that the choice of progestogen may matter for risk outcomes. The E3N cohort study (N=80,377 French women) found that oral micronized progesterone combined with estradiol was not associated with the elevated breast-cancer risk seen with synthetic progestins (Fournier A et al., Int J Cancer, 2008; PMID 17984078). The 2022 Menopause Society (NAMS) position statement notes that "the type of progestogen may influence breast cancer risk," and that micronized progesterone appears to have a more favorable profile than MPA (Menopause, 2022).

That distinction gives many clinicians and patients reason to prefer Prometrium or its generics over switching to a cheaper synthetic progestogen.

Who Uses Prometrium?

The two main patient groups are:

  • Postmenopausal women on estrogen therapy who need progestogen to protect the uterine lining. The standard dose is 200 mg orally once daily for 12 days per 28-day cycle in a cyclic regimen, or 100 mg nightly in a continuous regimen.
  • Women with secondary amenorrhea, dosed at 400 mg nightly for 10 days per the FDA-approved labeling.

Off-label uses in fertility support and luteal-phase supplementation are also common, though insurance coverage for those indications is less consistent.


The AbbVie Prometrium Copay Program: What It Is and How It Works

AbbVie operates a copay card program for Prometrium that allows eligible commercially insured patients to reduce their out-of-pocket cost. The program is not a guaranteed fixed dollar amount; AbbVie adjusts terms periodically, and the specific savings cap may differ from what you read on third-party coupon aggregator sites.

Eligibility Requirements

To use the AbbVie copay card for Prometrium, you generally must:

  1. Have a valid prescription for Prometrium from a licensed U.S. Prescriber.
  2. Have commercial (private) health insurance. Medicare Part D, Medicaid, TRICARE, or any other federal or state government-funded insurance program does not qualify.
  3. Be a U.S. Resident.
  4. Not be seeking reimbursement from any government program for the copay card savings.

These eligibility criteria are standard across most manufacturer copay programs. The reason government insurance is excluded relates to federal anti-kickback statutes.

How to Enroll

  1. Visit AbbVie's patient savings page directly (search "AbbVie myAbbVie Assist Prometrium" or go to abbvie.com). Do not rely solely on third-party coupon sites, because the dollar amounts shown there may be outdated.
  2. Register with your name, date of birth, and insurance information.
  3. Print, download, or receive a digital card.
  4. Present the card to the pharmacist at the point of sale alongside your insurance card.

The pharmacist runs your insurance first, then applies the copay card to the remaining balance up to the program's current maximum benefit.

Program Limitations to Know

Copay card programs typically cap the annual benefit. Once you hit that cap, you pay your normal copay for the rest of the year. Common caps in similar AbbVie programs run between $1,200 and $3,600 per calendar year, though the Prometrium-specific figure changes and must be verified at enrollment.

The HealthRX clinical team uses a three-tier cost check before recommending a savings route to any patient starting hormone therapy. Tier 1 is insurance coverage verification (formulary placement and prior authorization requirements). Tier 2 is manufacturer copay assistance for commercially insured patients. Tier 3 is a pivot to generic micronized progesterone or compounded progesterone if Tiers 1 and 2 leave the patient with more than $30/month out-of-pocket. This three-tier approach catches most affordability issues before the first prescription is sent to the pharmacy.


AbbVie myAbbVie Assist: Patient Assistance for the Uninsured

Patients who are uninsured or who have lost coverage may qualify for AbbVie's Patient Assistance Program (PAP), called myAbbVie Assist. This is separate from the copay card. Qualifying patients may receive Prometrium at no cost or low cost directly from the manufacturer.

Income and Insurance Criteria

MyAbbVie Assist uses income thresholds tied to the federal poverty level (FPL). Eligibility criteria as of 2025 generally require:

  • Household income at or below 400% of the FPL (approximately $58,320 for a single-person household in 2025 based on HHS poverty guidelines).
  • No current prescription drug insurance coverage, or coverage that has been exhausted.

Apply through AbbVie's assistance portal or ask your prescriber's office to submit paperwork on your behalf. Many telehealth and specialty practices have a dedicated prior-authorization or financial-assistance coordinator who can handle this.

Processing Time

PAP applications typically take 2 to 6 weeks to process. If you need Prometrium immediately, ask your pharmacy for a 7-day emergency supply at cash pay while the application is pending. At roughly $45 for a 30-day supply, a 7-day bridge costs approximately $10 to $12 at a discount pharmacy using a GoodRx or similar cash-pay coupon.


Generic Micronized Progesterone: The Fastest Way to Cut Costs

Brand Prometrium lost its period of exclusivity years ago. Generic micronized progesterone 100 mg and 200 mg capsules are manufactured by multiple companies including Teva Pharmaceuticals, Actavis (now Allergan/AbbVie), and Perrigo. These generics are bioequivalent to Prometrium per FDA standards.

What Generics Cost

At GoodRx pricing (January 2026 data), generic micronized progesterone 200 mg, 30 capsules ranges from approximately $18 to $55 depending on pharmacy chain and geographic location. Costco, Walmart, and independent pharmacies frequently come in at the lower end of that range.

The FDA's guidance on generic drug bioequivalence states that approved generics must demonstrate that the rate and extent of absorption falls within 80% to 125% of the reference listed drug, with a 90% confidence interval, in a pharmacokinetic study (FDA, 2022). For most patients, switching from brand Prometrium to a generic is clinically acceptable. If you notice a change in symptom control after switching, report it to your prescriber.

Insurance Formulary and Generic Tier Placement

Most commercial insurance plans place generic micronized progesterone on Tier 1 or Tier 2, meaning copays of $0 to $30 per month. Brand Prometrium often sits on Tier 3 or Tier 4, with copays ranging from $40 to over $100. Checking your plan's formulary before the prescription is written can save a significant amount.

The 2023 USPSTF recommendation on hormone therapy notes that individualization of HRT regimens is appropriate, and that out-of-pocket costs are a documented barrier to adherence (USPSTF, 2022). Poor adherence to progestogen reduces endometrial protection, making affordability a clinical, not just financial, issue.


Compounded Micronized Progesterone: Lower Cost, Different Regulatory Status

Compounded micronized progesterone is made by a compounding pharmacy using pharmaceutical-grade progesterone powder. It is not FDA-approved as a finished drug product, which means it has not undergone the same manufacturing quality controls as Prometrium or its generics.

Cost Comparison

Compounded progesterone averages approximately $25 per 30-day supply, making it the lowest-cost option on a per-fill basis. Compounding pharmacies typically offer it as oral capsules, topical creams, sublingual drops, or vaginal suppositories. Formulation options that are not available commercially (such as vaginally applied progesterone in a specific dose) represent a legitimate clinical reason to use compounding.

What the Guidelines Say

The Menopause Society (NAMS) advises caution with compounded hormones. Their 2022 position statement states: "Compounded hormone therapy is not recommended as a first-line therapy because of concerns about consistent dosing, sterility for injectable products, and lack of safety and efficacy data comparable to that of FDA-approved products."

Compounded progesterone products do not appear in FDA's Orange Book and are not subject to the same lot-release testing as approved drugs. A 2001 study in the journal Menopause found that commercially compounded progesterone creams had highly variable progesterone content compared to label claims (Cooper A et al., Menopause, 2001; PMID 11584882).

For oral capsule formulations from an accredited 503B outsourcing facility, the variability concern is smaller, but the lack of approved-drug status remains. If you choose compounded progesterone because of cost, use a pharmacy accredited by the Pharmacy Compounding Accreditation Board (PCAB) or one operating as an FDA-registered 503B outsourcing facility.


Navigating Insurance Coverage for Prometrium

Insurance is often the single largest driver of what you actually pay. Three factors determine your net cost.

Formulary Tier Placement

Call the member services number on your insurance card and ask specifically: "Is micronized progesterone 100 mg and 200 mg on the formulary? What tier? What is my copay?" Also ask whether Prometrium brand is covered and at what tier.

If generic micronized progesterone is on Tier 1 with a $0 to $10 copay, there is little reason to pursue the manufacturer copay card. If the generic is non-formulary or on a high tier, the copay card or a formulary exception request may be worth pursuing.

Prior Authorization

Some insurers require prior authorization (PA) for hormone therapy, particularly for patients under 50 or for doses outside standard labeling. Your prescriber's office submits clinical documentation. Common PA criteria for MHT include confirmation of menopause symptoms, a documented uterus (for progestogen add-back), and absence of contraindications.

PA approval typically takes 1 to 14 business days. An urgent PA request can sometimes be processed in 24 to 72 hours.

Step Therapy

A smaller number of plans require patients to try a lower-cost progestogen (such as medroxyprogesterone acetate) before approving progesterone. If your clinician believes micronized progesterone is medically necessary for you specifically (for example, due to MPA intolerance or a preference to avoid synthetic progestins based on the E3N cohort data), your prescriber can request a step-therapy exception citing clinical grounds. The American College of Obstetricians and Gynecologists (ACOG) has published guidance supporting clinician discretion in progestogen selection (ACOG Practice Bulletin 141).


Third-Party Coupons and Discount Pharmacy Programs

If the manufacturer copay card does not apply to your situation, or if you need a quicker solution, several third-party savings options are worth considering.

GoodRx and Similar Services

GoodRx, RxSaver, and NeedyMeds aggregate pharmacy discount pricing and provide free-to-use coupons. These coupons are not insurance; they are negotiated cash-pay rates. Using a GoodRx coupon at a pharmacy means you pay cash-pay pricing and the transaction does not count toward your insurance deductible.

At major pharmacy chains in January 2026, GoodRx prices for generic micronized progesterone 200 mg (30 capsules) range from approximately $18 (Costco) to $38 (CVS). These prices vary by ZIP code.

You cannot legally stack a GoodRx coupon on top of a manufacturer copay card. Pick the lower of the two options.

Mark Cuban Cost Plus Drugs

Mark Cuban's Cost Plus Drugs (costplusdrugs.com) lists generic micronized progesterone at its cost-plus-15% model. As of early 2026, the platform lists micronized progesterone 100 mg capsules. Prices and availability change; check the site directly. Prescriptions must be sent to Cost Plus Drugs directly; they cannot be transferred from a retail pharmacy chain electronically in all states.

NeedyMeds and State Pharmaceutical Assistance Programs

NeedyMeds (needymeds.org) aggregates both manufacturer PAPs and state pharmaceutical assistance programs (SPAPs). Some states offer SPAPs that help low-income seniors who fall into Medicare Part D coverage gaps. Check NeedyMeds for your specific state's programs.


When Brand Prometrium May Be Worth the Higher Price

Most patients do well on generic micronized progesterone. There are narrow situations where the brand may be clinically preferable.

Some patients report differences in tolerability between manufacturers of generic micronized progesterone, particularly relating to the peanut oil base used in Prometrium capsules (Prometrium contains peanut oil, and is contraindicated in patients with peanut allergy). Some generic formulations use a different oil base, which may matter for patients with specific sensitivities. Ask your pharmacist to confirm the inactive ingredient profile of the specific generic they stock.

If you have a peanut allergy, brand Prometrium is contraindicated per its FDA label. Compounded micronized progesterone in a peanut-oil-free base is a reasonable clinical alternative in that case (FDA Prometrium label).


Practical Steps to Lower Your Prometrium Cost Right Now

A short checklist your HealthRX care team recommends before your first fill:

  1. Check your formulary. Log into your insurance portal or call member services. Confirm whether generic micronized progesterone is covered and at what tier.
  2. Ask your prescriber to write for the generic. A prescription written as "micronized progesterone 200 mg capsules" (without "brand only") allows the pharmacist to dispense a less expensive generic.
  3. Look up GoodRx pricing at your local pharmacies. This takes two minutes and can identify the cheapest pharmacy within a few miles.
  4. Check AbbVie's copay card. If you have commercial insurance and the brand is preferred on your plan, the copay card may bring your cost below the generic cash price.
  5. Apply to myAbbVie Assist if you are uninsured or underinsured and meet income criteria.
  6. Ask about 90-day supplies. Many pharmacies and mail-order programs discount 90-day supplies by 10% to 20% versus three separate 30-day fills.
  7. Talk to your clinician about compounding if all of the above still leaves you above $30/month and a compounding option is clinically appropriate for your regimen.

The E3N cohort data showing a favorable safety signal for micronized progesterone combined with estradiol gives clinicians reason to advocate strongly for insurance coverage when medically indicated. A well-written PA letter citing the 2022 NAMS position statement and the E3N findings (PMID 17984077) can support a formulary exception request.


Frequently asked questions

How can I afford Prometrium?
Start by asking your prescriber to write for generic micronized progesterone, which averages $18-$55 per 30-day supply at discount pharmacies. If you have commercial insurance, check whether AbbVie's Prometrium copay card applies to your plan. Uninsured patients may qualify for myAbbVie Assist, AbbVie's no-cost patient assistance program. GoodRx and similar coupons are free to use and can cut cash-pay costs substantially at major pharmacy chains.
What is the manufacturer coupon for Prometrium?
AbbVie offers a copay savings card for Prometrium through its patient savings program. Eligible patients must have commercial (private) health insurance. Medicare, Medicaid, and other government-funded coverage do not qualify. The specific savings amount and annual cap change periodically, so verify the current offer directly at abbvie.com or by calling AbbVie patient support.
Does insurance cover Prometrium?
Most commercial insurance plans cover generic micronized progesterone, usually on Tier 1 or Tier 2. Brand Prometrium is less consistently covered and may require prior authorization. Medicaid formularies vary by state. Medicare Part D plans cover progesterone for approved indications, though plan-specific tier placement determines your copay. Call your insurance member services line to confirm formulary status before filling.
Is there a generic version of Prometrium?
Yes. Generic micronized progesterone 100 mg and 200 mg capsules are FDA-approved and available from multiple manufacturers including Teva and Perrigo. They are bioequivalent to brand Prometrium and substantially cheaper. Ask your pharmacist or prescriber to dispense the generic.
What is the cash price for Prometrium without insurance?
Brand Prometrium averages approximately $45 per 30-day supply at discount pharmacies in 2026. Generic micronized progesterone averages $18-$55 depending on pharmacy and location. Compounded micronized progesterone from a compounding pharmacy averages around $25 per fill but is not an FDA-approved product.
Can I use GoodRx for Prometrium?
Yes. GoodRx and similar cash-pay coupon services work at most major pharmacy chains for both brand Prometrium and generic micronized progesterone. Note that using GoodRx means paying cash pay, which does not count toward your insurance deductible. Compare the GoodRx price against your insurance copay and choose the lower option.
Is compounded progesterone as effective as Prometrium?
Compounded oral micronized progesterone from a reputable 503B outsourcing facility or PCAB-accredited pharmacy uses the same active ingredient as Prometrium. However, it is not FDA-approved, has not undergone the same standardized testing, and quality can vary between compounders. The Menopause Society recommends FDA-approved products as first-line therapy and suggests compounding only when a commercially available product cannot meet a patient's clinical needs.
Can I use the AbbVie copay card with Medicare?
No. Federal law prohibits manufacturer copay cards from being used by patients covered by Medicare, Medicaid, TRICARE, or other government-funded programs. Medicare patients should look into the Extra Help (Low Income Subsidy) program through SSA.gov, or ask their pharmacist about Medicare Savings Programs.
How do I apply for the Prometrium patient assistance program?
Visit abbvie.com and search for myAbbVie Assist, or ask your prescriber's office to initiate the application. You will need to provide proof of income, insurance status, and a valid prescription. Processing typically takes 2 to 6 weeks. If you need medication immediately, ask your pharmacy for a short bridge supply using a GoodRx coupon while your application is reviewed.
Does Prometrium contain peanut oil?
Yes. Brand Prometrium capsules contain peanut oil as an inactive ingredient. Prometrium is contraindicated in patients with a known peanut allergy. Some generic formulations use alternative oil bases. If you have a peanut allergy, tell your prescriber and pharmacist before filling any progesterone capsule prescription. A compounded peanut-oil-free formulation may be a clinically appropriate alternative.
What dose of Prometrium is used for menopause?
For continuous combined hormone therapy, the standard dose is 100 mg orally once nightly. For cyclic therapy paired with an estrogen, the standard dose is 200 mg orally once daily for 12 consecutive days per 28-day cycle. Doses for secondary amenorrhea are 400 mg nightly for 10 days per the FDA-approved labeling. Your prescriber will select the dose appropriate for your specific clinical situation.
How long does Prometrium take to work for menopause symptoms?
Prometrium does not directly treat hot flashes or vasomotor symptoms; estrogen does. Progesterone's role in combined HRT is primarily endometrial protection and sleep support. Some women report improved sleep within the first 1 to 2 weeks of starting nightly micronized progesterone, likely due to its metabolite allopregnanolone's activity at GABA-A receptors. Endometrial protection begins with the first cycle.

References

  1. Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. 2008;107(1):103-111. https://pubmed.ncbi.nlm.nih.gov/17984078/
  2. The Menopause Society (NAMS). Hormone Therapy Position Statement 2022. Menopause. 2022;29(7):767-794. https://menopause.org/for-women/menopauseflashes/menopause-symptoms-and-treatments/hormone-therapy-an-updated-look-at-the-evidence
  3. US Food and Drug Administration. Prometrium (progesterone, USP) Prescribing Information. 2018. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019781s027lbl.pdf
  4. US Food and Drug Administration. Generic Drug Facts. 2022. https://www.fda.gov/drugs/generic-drugs/generic-drug-facts
  5. US Preventive Services Task Force. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: Recommendation Statement. JAMA. 2022;328(17):1740-1746. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication
  6. American College of Obstetricians and Gynecologists. Practice Bulletin 141: Management of Menopausal Symptoms. Obstet Gynecol. 2014;123(1):202-216. https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2014/01/management-of-menopausal-symptoms
  7. Cooper A, Spencer C, Whitehead MI, et al. Systemic absorption of progesterone from Progest cream in postmenopausal women. Menopause. 2001;8(1):61-66. https://pubmed.ncbi.nlm.nih.gov/11584882/
  8. Kessler EM, Schwartz JB, Hersh AL, et al. Out-of-pocket costs and adherence to menopausal hormone therapy. JAMA Intern Med. 2023;183(4):e230428. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2809128